Affiliation:
1. MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico
2. Faculty of Chemistry, National Autonomous University of Mexico, Mexico City, Mexico
3. Instituto Nacional de Geriatra, Mexico City, Mexico
Abstract
Abstract
Background: Diabetes has been described as a heterogeneous entity which can be studied through data-driven subgroups (obesity related [MOD], severe-insulin deficient [SIID], severe-insulin resistant [SIRD] and age-related diabetes [MARD]). However, trends in prevalence and mortality risk are still unclear. Aims: To analyze diabetes subgroup trends and to evaluate mortality risk in the US. Methods: Data and follow-up causes of mortality (all-cause, cardiovascular disease, and diabetes specific) was collected from NHANES cycles 1999–2018. Subgroup diabetes classification was performed using the self-normalizing neural networks algorithm using clinical parameters (HbA1c, time since diabetes diagnosis, HOMA2-IR, HOMA2-B, and BMI) proposed by Bello-Chavolla et al (https://bit.ly/3jSm1xv). Prevalence was estimated using sample weights. 2-year cycles were used as a continuous variable to evaluate the biannual change (BC) of the overall prevalence of diabetes and subgroups. Trends were stratified according to race. Cox-proportional and Fine-Gray semiparametric hazard regression models were used to evaluate mortality risk. Results: Data from 59,204 adult subjects was extracted for trend analysis. Follow-up information was obtained for 3,980 subjects. Diabetes prevalence in the US increased from 8.2% (95%CI 7.8–8.6) in 1999–2000 to 13.9% (95% CI 13.4–14.4) in 2017–2018 (BC 1.38%, 95% CI 1.20–1.56, p<0.001). Non-Hispanic Blacks had the largest increase in diabetes prevalence (BC: 1.40%, 95%CI 0.71–2.08, p=0.027), followed by Non-Hispanic Whites (BC: 1.36%, 95%CI 1.13–1.58, p<0.001), and Mexican Americans (BC: 1.33%, 95%CI 1.20–1.54, p<0.001). Regarding diabetes subgroups, MARD had the highest prevalence, with a moderate increase over time; however, MOD had the greatest increase over time (1.5%, [95%CI 1.2–1.8] to 4.5% [95%CI 4.0–5.0]; BC: 0.73% [95%CI 0.60–0.86], p<0.01). Both SIRD and SIID had non-significant increases in prevalence during the studied period. Non-Hispanic Blacks had an increase in the prevalence in MOD and SIID, Mexican Americans in MOD and SIRD, and non-Hispanic Whites in MOD and MARD. Compared with MOD, the risk for all-cause mortality was higher for MARD (HR 2.9 95% CI: 2.1–3.9), SIRD (HR 2.0 95% CI: 1.5–2.8), and SIID (HR 1.6 95% CI: 1.1–2.3). For CVD mortality, only MARD (HR 2.8 95% CI: 1.4–5.7) and SIRD (HR 2.5 95% CI: 1.2–5.3) displayed higher risk. For diabetes-specific mortality, only MARD (HR 2.2 95% CI: 1.3–3.7) was associated. Conclusion: There is an overall increase in diabetes prevalence and its subgroups from 1999 to 2018; MORD had the highest increase. The risk for all-cause, CVD and diabetes-specific mortality was different among subgroups. Our results supports the use of diabetes subgroups for a better understanding of diabetes and its complications.
Subject
Endocrinology, Diabetes and Metabolism
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献